About a-team Marketing Services
The knowledge platform for the financial technology industry

A-Team Insight Briefs

Diginex Adds Supply Chain Risk Tech to Platform

Subscribe to our newsletter

ESG, sustainability and compliance specialist Diginex has integrated Risk-to-Remedy as an end-to-end supply chain due diligence solution.

The framework combines worker-level evidence, prioritised remediation and regulator-ready reporting to verify company declarations. It builds on the technologies of Lumen for risk assessment and Apprise for worker engagement, alongside the acquired expertise of The Remedy Project in grievance mechanisms.

Future features will enable clients to manage assessments, collect evidence, monitor non-compliance and maintain records.

Subscribe to our newsletter

Related content

WEBINAR

Upcoming Webinar: The Data Office at a Crossroads — AI Governance, Organisational Design, and the Evolving Mandate of the CDO

Date: 28 July 2026 Time: 10:00am ET / 3:00pm London / 4:00pm CET Duration: 50 minutes Who owns AI governance in a capital markets firm – and is the Data Office structured to bear that weight? These questions sit at the heart of A-Team Research’s latest findings, presented here for the first time: the combined...

BLOG

Twelve Leading Data Lineage Solutions for Capital Markets

The ability to trace the journey of data from its origin to its final report is no longer a luxury but a regulatory and operational necessity. As firms grapple with the intensifying requirements of regulations such as BCBS 239, GDPR and the shifting landscape of MiFID II, the “black box” approach to data management has...

EVENT

AI in Capital Markets Summit London

Now in its 3rd year, the AI in Capital Markets Summit returns with a focus on the practicalities of onboarding AI enterprise wide for business value creation. Whilst AI offers huge potential to revolutionise capital markets operations many are struggling to move beyond pilot phase to generate substantial value from AI.

GUIDE

AI in Capital Markets Handbook 2026

AI adoption in capital markets has moved into a more disciplined phase. The priority is now controlled deployment: where AI can be used safely, where it can deliver measurable value, and how outputs can be governed, monitored and evidenced. The 2026 edition of the AI in Capital Markets Handbook examines how AI is being applied...